Liranaftate is a thiocarbamate antifungal agent that functions by inhibiting the enzyme squalene epoxidase, thereby blocking ergosterol biosynthesis within fungal cells. This compound is indicated for… Read more
Liranaftate is a thiocarbamate antifungal agent that functions by inhibiting the enzyme squalene epoxidase, thereby blocking ergosterol biosynthesis within fungal cells. This compound is indicated for the treatment of various fungal infections and systemic mycosis caused by susceptible organisms. The collection of Liranaftate reference standards provided here includes the active pharmaceutical ingredient, along with essential pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These high-quality materials are critical for laboratories performing rigorous analytical testing, impurity profiling, and method validation to ensure pharmaceutical quality control. By utilizing these precise standards, researchers and analytical chemists can accurately identify and quantify degradation products and metabolic pathways, supporting the development and regulatory compliance of antifungal therapeutic formulations.